MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./300/0.1/20.09.24 Stock

Warrant

DE000MG03821

Market Closed - Börse Stuttgart 02:07:07 2024-07-12 pm EDT
0.142 EUR +2.90% Intraday chart for MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./300/0.1/20.09.24
Current month-14.81%
1 month+32.69%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 0.142 +2.90%
24-07-11 0.138 +8.66%
24-07-10 0.127 -14.19%
24-07-09 0.148 +0.68%
24-07-08 0.147 -2.65%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 02:07 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG0382
ISINDE000MG03821
Date issued 2024-03-12
Strike 300 $
Maturity 2024-09-20 (70 Days)
Parity 10 : 1
Emission price 0.15
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.205
Lowest since issue 0.049
Spread 0.034
Spread %19.43%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
224.9 USD
Average target price
277.8 USD
Spread / Average Target
+23.50%
Consensus